Indonesia's Sumedang Regency and Singapore-based Docquity launch AI-driven health platform to tackle tuberculosis

August 13, 2024 | Tuesday | News

Puskesmas AI platform expected to have a significant impact on healthcare in Sumedang

Indonesia's Sumedang Regency and Singapore-based Docquity launch AI-driven health platform to tackle tuberculosis

Docquity, a leading health tech company established in 2015, has announced its expansion into the B2G sector with the launch of the Puskesmas AI platform in partnership with Sumedang Regency, West Java.

This initiative builds on the success of Singapore-based startup Docquity’s social platform, which connects doctors across specialties throughout the Asia Pacific region, including Indonesia. Endorsed by the Mayor of Sumedang and the General Secretary of West Java Province, the platform has quickly become a valuable assistant to healthcare professionals involved in the pilot.

The primary objective of this programme is to enhance the capabilities of Puskesmas by utilising Generative AI supported by credible data and insights from the existing Docquity Platform. The initiative focuses on critical health issues prioritised by the Sumedang Regency for the sake of improving the health of the people of Sumedang.

Puskesmas AI, developed by Docquity, utilises GenAI Technology compliant with Indonesian and European data protection regulations. This platform will assist HCPs in enhancing their knowledge and provide responses based on credible data from the Ministry of Health, scientific journals, WHO, and other local Sumedang Government credible sources. The Puskesmas AI platform aims to provide comprehensive support to HCPs, enabling them to make informed decisions and improve patient outcomes.

Mayor of Sumedang 2018-2023, Dr Dony Ahmad Munir, expressed his support, "Puskesmas AI platform will be instrumental in improving the knowledge and capabilities of our healthcare professionals, ultimately benefiting the health of our community. By addressing critical health issues such as Tuberculosis, Stunting, and Hypertension, we can make significant strides in improving public health in Sumedang.”

 

© Copyright 2024, MM Activ Sci-Tech Communications. All Rights Reserved.

Website Design & Developed By : SCI Knowledge Interlinks